Clinical Focus
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves obinutuzumab to reduce relapse risk in childhood-onset idiopathic nephrotic syndrome
2
FDA approves baricitinib for adolescents with severe alopecia areata
3
GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
4
FAQ: What's new in IDSA's histoplasmosis treatment guidance?
5